Cargando…
Neurodifferentiation and Neuroprotection Potential of Mesenchymal Stromal Cell-Derived Secretome Produced in Different Dynamic Systems
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and is characterized by the degeneration of the dopamine (DA) neurons in the substantia nigra pars compacta, leading to a loss of DA in the basal ganglia. The presence of aggregates of alpha-synuclein (α-synuclein) is seen...
Autores principales: | Marques, Cláudia Raquel, Fuzeta, Miguel de Almeida, dos Santos Cunha, Raquel Medina, Pereira-Sousa, Joana, Silva, Deolinda, Campos, Jonas, Teixeira-Castro, Andreia, Sousa, Rui Amandi, Fernandes-Platzgummer, Ana, da Silva, Cláudia L., Salgado, António José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215864/ https://www.ncbi.nlm.nih.gov/pubmed/37238911 http://dx.doi.org/10.3390/biomedicines11051240 |
Ejemplares similares
-
Impact of umbilical cord mesenchymal stromal/stem cell secretome and cord blood serum in prostate cancer progression
por: Sousa, André, et al.
Publicado: (2023) -
Metabolic regulation of neurodifferentiation in the adult brain
por: Maffezzini, Camilla, et al.
Publicado: (2020) -
Histone modifications in neurodifferentiation of embryonic stem cells
por: Huang, Min, et al.
Publicado: (2021) -
From Promise to Reality: Bioengineering Strategies to Enhance the Therapeutic Potential of Extracellular Vesicles
por: de Almeida Fuzeta, Miguel, et al.
Publicado: (2022) -
Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
por: Ferreira, Joana R., et al.
Publicado: (2018)